[Retracted] Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study

Table 3

Baseline characteristics of patients used haemocoagulase agkistrodon for injection or tranexamic acid before and after propensity score matching.

Baseline	Before propensity score matching			After propensity score matching
	Haemocoagulase agkistrodon ()	Tranexamic acid ()		Haemocoagulase agkistrodon ()	Tranexamic acid ()
Age (years)			0.93			0.74
Body mass index (kg/m^2)	23.38 (20.62, 25.53)	22.96 (21.40, 24.42)	0.46	23.24 (21.72, 26.61)	23.10 (21.11, 24.77)	0.39
Prostate volume (mL)	51.65 (32.46, 82.32)	43.60 (30.66, 71.24)	0.43	52.38 (34.68, 79.88)	44.61 (32.65, 68.43)	0.81
Systolic pressure (mmHg)	132.00 (121.00, 143.00)	133.00 (120.00, 140.00)	0.98			0.47
Diastolic pressure (mmHg)	79.00 (70.00, 85.00)	80.00 (70.00, 90.00)	0.40			0.96
Fasting blood glucose (ng/mL)	5.12 (4.80, 5.60)	5.17 (4.42, 5.60)	0.61	5.12 (4.83, 5.59)	5.07 (4.51, 5.50)	0.36
Hypertension status ( [%])			0.08			0.53
Yes	13 (11.71%)	11 (22.45%)		5 (13.16%)	7 (18.42%)
No	98 (88.29%)	38 (77.55%)		33 (86.84%)	31 (81.58%)
History of smoking ( [%])			0.75			0.60
Yes	28 (25.23%)	13 (27.66%)		9 (23.68%)	11 (28.95%)
No	83 (74.77%)	36 (72.34%)		29 (67.32%)	27 (71.05%)
History of drinking ( [%])			0.69			0.61
Yes	30 (27.03%)	11 (23.91%)		12 (31.58%)	10 (26.32%)
No	81 (72.97%)	38 (76.09%)		26 (68.42%)	28 (73.68%)